Article
Association between with Serum neurofilament light and neurochemistry deficits in patients with spinocerebellar ataxia type 3
2022-10-14
Abstract excerpt
Extensive evidence supports the claim that serum neurofilament light chain (sNfL) can be used as a biomarker for monitoring disease severity in patients with spinocerebellar ataxia type 3 (SCA3). However, little is known about the associations between sNfL levels and neurochemical alterations in SCA3 patients. Serum samples were collected from ATXN3 mutation carriers ( n = 20) and normal controls ( n = 14). sNfL...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e4d87a7a-6e71-5352-92e7-de3d96c74004
- DOI
- 10.21203/rs.3.rs-2132253/v1
